CSBR NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Champions Oncology Inc · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 6.13 USD
0.0% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -0.6% below the Trend Line and sits at 19.4% of its 52-week range. The latest completed week returned 0.0%, after a -7.5% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is expensive relative to peers. Options positioning is bullish with 39/100 conviction, while the latest news-sentiment score is 51/100. Near-term considerations: volume confirmation is below normal; earnings are due in 52d.

Setup score 25 out of 100
Latest Close 6.13 USD 24 Jul 2026
1W Return 0.0% latest completed week
4W Return -7.5% short-term follow-through
12W Return 2.3% quarterly tape
Trend Breadth 1.9% 1 of 52 weeks active
Volume Ratio 0.5x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 0.0% Latest completed week; four-week move -7.5%. Indicator stack 1/52 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bullish 39/100 conviction; expected move 48.9%. News sentiment 51/100 48 relevant articles in the latest sentiment read. Event risk 52d Next report is scheduled for 21 Sep 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -0.6% below the Trend Line and sits at 19.4% of its 52-week range. The latest completed week returned 0.0%, after a -7.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1412-week average 0.08

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.14Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -7.5% over four weeks, 2.3% over 12 weeks, and -1.8% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W0.0%
4W-7.5%
12W2.3%
26W-9.2%
52W-1.8%
Active trend streak0 weeks
Active weeks in one year1
Trend breadth1.9%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.32Latest activity-pressure read.
Pressure change-44.8%Four-week change in activity pressure.
Leadership-12.42Latest relative-leadership reading.
RS change-7.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 30 Apr 2025 Field coverage 88% Model confidence 76%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength7/100Blend of value, momentum, and quality. Underlying universe rank 94; rank 1 is best.
Value21/100Relative valuation strength. Underlying universe rank 80; rank 1 is best.
Quality20/100Profitability and accounting quality. Underlying universe rank 81; rank 1 is best.
Momentum27/100Medium-term price momentum. Underlying universe rank 74; rank 1 is best.
Growth24/100Revenue and earnings growth. Underlying universe rank 77; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
1.5x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
6.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
45.9%
Gross profit retained from each unit of revenue.
Operating margin
-4.1%
Operating profit retained from revenue.
Free-cash-flow margin
8.6%
Free cash flow generated from revenue.
Return on invested capital
-83.5%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-1.1%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-0.3%
Net share repurchases relative to market value.
Shareholder yield
-0.3%
Dividend yield plus net buyback yield.
Net debt / EBITDA
2.2x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

CSBR shows bullish options pressure with a 39/100 conviction score, put-call volume ratio of 0.51, expected move of 48.9%, and Sharemaestro trend signal inactive.

Conviction39/100
Expected move48.9%
Put/call volume0.51
Pressure35
Speculation25
Volatility96
Trend agreement37
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment51/100

Weighted news tone is neutral across 48 relevant articles.

8 positive · 33 neutral · 7 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings52dNext report is scheduled for 21 Sep 2026; event risk rises as the date approaches.
Options expected move48.9%Nearest-chain priced movement where available.
52-week drawdown-29.9%Distance below the 52-week high.
13-week volatility6.2%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2613 weeks finished lower.
Best week+15.0%Week of 12 Jun.
Worst week-13.1%Week of 3 Jul.
Latest week+0.0%Week of 24 Jul.

Shape of recent returns

Strong gains5
Modest gains7
Flat weeks1
Modest losses9
Sharp losses4
Recent vol6.2%13-week weekly-return volatility.
Base vol5.7%52-week weekly-return volatility.
Up/down split23/27Count of positive and negative weeks in the 52-week window.
Average skew4.9% / -3.9%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape23/100

Trend, activity pressure, participation, and risk combine to a 23/100 tape read.

 Indicator analysis28/100

Latest 12-week confirmation: trend 0/12, activity pressure 10/12, relative leadership 0/12.

Activity pressure 0.14; No reversal markers Factors17/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 74; Small Cap Core rank 84 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options52/100

CSBR shows bullish options pressure with a 39/100 conviction score, put-call volume ratio of 0.51, expected move of 48.9%, and Sharemaestro trend signal inactive.

Bullish · Call-side pressure · Expected move 48.9% Sentiment51/100

Weighted news tone is neutral across 48 relevant articles.

CSBR Stock Dips Post Q4 Earnings Despite Record Revenue Growth, AI Push Insiders50/100

No recent insider transaction evidence is stored.

 Earnings52d

Next report is scheduled for 21 Sep 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 20266.13 USD0.0%6.17 USD6.29 USD0.32-12.4218.6KOff
17 Jul 20266.13 USD5.3%6.20 USD6.29 USD0.53-14.1661.8KOff
10 Jul 20265.82 USD1.0%6.23 USD6.30 USD0.50-22.6946.1KOff
3 Jul 20265.76 USD-13.1%6.26 USD6.30 USD0.63-23.0415.9KOff
26 Jun 20266.63 USD4.9%6.27 USD6.31 USD0.58-11.5939.7KOff
19 Jun 20266.32 USD-2.8%6.27 USD6.30 USD0.41-20.2233.9KOff
12 Jun 20266.50 USD15.0%6.29 USD6.30 USD0.46-16.8431.3KOff
5 Jun 20265.65 USD-3.2%6.30 USD6.30 USD0.42-26.7728.9KOff
29 May 20265.83 USD-2.9%6.33 USD6.30 USD0.42-28.4144.2KOff
22 May 20266.01 USD-3.1%6.37 USD6.30 USD0.21-24.5866.3KOff
15 May 20266.20 USD3.0%6.40 USD6.29 USD-0.18-21.6757.0KOff
8 May 20266.02 USD0.5%6.40 USD6.28 USD-0.51-24.6460.7KOff
1 May 20265.99 USD2.1%6.42 USD6.27 USD-0.63-21.4729.8KOff
24 Apr 20265.87 USD-2.8%6.43 USD6.27 USD-0.81-22.3143.2KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.